HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Pfizer

This article was originally published in The Rose Sheet

Executive Summary

Pfizer: Consumer health care sales for the third quarter rose 8% to $177 mil., driven by revenue from the Bain de Soleil suncare line, acquired from Procter & Gamble in 1995, and the Cortizone anti-itching product and Hemorid hemorrhoid treatment, purchased from Thompson Medical in April, the company reported Oct. 14. Consolidated sales advanced 10.4% to $2.8 bil., while net income shot up 20.9% to $514 mil. over the prior-year period. For the nine months, revenue climbed 11.9% to $8.15 bil. Net earnings increased 22.6% to $1.43 bil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel